https://market-scope.com

Market ScopeMarket Scope 314-835-0600 Sign In Join ProductsGlobal & Regional Market Reports Ophthalmic Market Trends Atlases Disease Models Ophthalmic Newsletter Surveys Primary Research News Market Scope+ Methodology About Market Scope Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis Choose Your Experience Industry Professional Medical Professional Over 500 Clients, Large & Small from Around the World, Have Trusted Market Scope Data & Analysis Latest Market Reports Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience. 358 Comprehensive Pages 35 Competitors Profiled 11 IOL Categories Forecasted 8 Geographic and Economic Breakouts 2024 IOL Market Report: Global Analysis for 2023 to 2029, March, 2024 The “2024 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.  This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs. Additionally, 34 companies are profiled, with discussion of their products, strategic market position, background, and outlook. Show Latest Reports Latest Industry News & Trends 9/20/2024 BreakingDealsPrivate Equity Bausch + Lomb Explores Sale to Separate from Bausch Health Bausch + Lomb is working with Goldman Sachs to explore a sale of the company, the Financial Times reported Sept. 14, with private equity the most likely buyer. The move is being evaluated as a way ... Read Article 9/20/2024 BreakingEuropeRegulationRetina Apellis Receives Negative CHMP Opinion on Pegcetacoplan in GA After Re-examination Apellis Pharmaceuticals announced Sept. 20 that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) had reaffirmed its June 2024 negative opinion on the company’s ... Read Article 9/20/2024 BreakingStudySurgical NYU Langone Hails Recovery of Man Over a Year after Landmark Whole Eye Transplant A surgical team at NYU Langone Health performed the world’s first whole eye and partial-face transplant in May 2023 for Aaron James, who had survived a high-voltage electrical accident at work. Ove... Read Article 9/19/2024 MeetingNewsletter 2024 World Ophthalmology Congress Draws Thousands to Vancouver Nearly 3 thousand attendees from 127 countries participated in the 2024 World Ophthalmology Congress (WOC), the biennial meeting of the International Council of Ophthalmology (ICO). Over 500 attend... Read Article 9/20/2024 BreakingDealsDry Eye NovaBay to Sell Avenova Products for $9.5 Million as Part of Dissolution Plan NovaBay Pharmaceuticals has agreed to sell its Avenova products to PRNPhysician Recommended Nutriceuticals for $9.5 million in cash, the companies announced Sept. 20. The deal is expected to close ... Read Article 9/20/2024 BreakingDry EyeRegulation US FDA Warns Regener-Eyes Maker Over Plant Conditions, Unapproved Products The US FDA has sent a warning letter to Regenerative Processing Plant in Palm Harbor, Florida, finding fault with its manufacturing processes and raising concerns that its eye drop products may sti... Read Article 9/20/2024 AIBreakingDiagnosticIndiaRegulationRetina Indian Regulators Approve First Ophthalmic AI Software—Medios DR from Remidio India’s Remidio announced Sept. 13 that regulators there had approved its Medios DR software for autonomous detection of diabetic retinopathy (DR). Medios DR becomes the first ophthalmic artificial... Read Article 9/20/2024 AllergyBreakingChinaDealsRegulation Nicox Reports that Ocumension Has Gained Approval for Zerviate in China France’s Nicox announced Sept. 18 that partner Ocumension Therapeutics had received regulatory approval in China to commercialize Nicox’ Zerviate (cetirizine ophthalmic solution) 0.24% for ocular i... Read Article Show More Articles Provider Surveys & Interviews Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard! Choose Your Own Adventure Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria. Safe, Secure & On Any Device We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you. Pre-Qualified Invitations We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified. Better Data = Better Decisions A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports. Learn More Register Today Download the Market Scope+ app to get started! Market Scope Methodology A Multi-Step Approach for Accurate & Timely Data Proprietary data 20+ years of physician survey data Disease models Cultivated database of physicians, ASCs, and hospitals Insight from our team of in-house industry experts Public data Attendance and participation at major, worldwide meetings Public health systems and registries Clinical study data Analysis of company-published financial reports Extensive analysis Integrated disease models Expert-based segmentation Integrate and reconcile Continuous feedback loop Integration of survey data Triangulation of results Cross-model analysis Reconciliation to company revenues Produce products covering key medical markets Medical devices Drugs/biologics Equipment Providers Gather feedback New market insights Client requests Landmark study evaluations Incorporate and revise Forecasting models Analytical tools and methods Learn More Join Market Scope Today Register A Corporate Account A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data. Topics of Interest Select one or more Cataract Refractive Glaucoma Retina Diagnostics Pharmaceuticals Surgical Devices Dry Eye Cornea Other No elements found. Consider changing the search query. List is empty. Products of Interest Select one or more Comprehensive Report Quarterly Update Newsletter Custom Research Other No elements found. Consider changing the search query. List is empty. Register Register A Clinical Account A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard. Country Select your country... No matching countries found. List is empty. Practice Role Register Market Scope 13421 Manchester Road, Suite 101 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email: info@market-scope.com Careers at Market Scope | Privacy Policy ©2024 Market Scope, LLC. All Rights reserved.enen1727379050https://market-scope.com